| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA3 NCOA6 DCAF6 TBL1Y YAP1 ZMYND8 DYRK1A RAD54L2 MED1 TAF6 ZNF541 | 1.27e-05 | 562 | 79 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 7.53e-05 | 21 | 79 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 8.69e-05 | 22 | 79 | 3 | GO:0050321 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 9.23e-05 | 4 | 79 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 9.68e-05 | 582 | 79 | 10 | GO:0140297 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 9.98e-05 | 61 | 79 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA3 NCOA6 DCAF6 TBL1Y YAP1 ZMYND8 TNRC6A DAB2 DYRK1A GRB14 RAD54L2 MED1 TAF6 ZNF541 | 1.65e-04 | 1160 | 79 | 14 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA3 NCOA6 SALL1 HEY1 YAP1 ZNF618 ZMYND8 SRF KMT2A MED1 TAF6 | 1.78e-04 | 753 | 79 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.97e-04 | 303 | 79 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA3 NCOA6 DCAF6 SASH1 TBL1Y YAP1 ZMYND8 TNRC6A DAB2 DYRK1A GRB14 RAD54L2 MED1 TAF6 ZNF541 | 2.43e-04 | 1356 | 79 | 15 | GO:0060090 |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 3.26e-04 | 34 | 79 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 5.84e-04 | 363 | 79 | 7 | GO:0106310 | |
| GeneOntologyMolecularFunction | protein kinase activity | 5.95e-04 | 600 | 79 | 9 | GO:0004672 | |
| GeneOntologyMolecularFunction | chromatin binding | 6.51e-04 | 739 | 79 | 10 | GO:0003682 | |
| GeneOntologyMolecularFunction | tau protein binding | 8.00e-04 | 46 | 79 | 3 | GO:0048156 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 1.21e-03 | 53 | 79 | 3 | GO:0030331 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.31e-03 | 417 | 79 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 1.79e-03 | 16 | 79 | 2 | GO:0042043 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.79e-03 | 16 | 79 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 1.91e-03 | 709 | 79 | 9 | GO:0016773 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.92e-03 | 446 | 79 | 7 | GO:0004674 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 2.15e-03 | 229 | 79 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 2.27e-03 | 18 | 79 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.09e-03 | 21 | 79 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | kinase activity | 3.15e-03 | 764 | 79 | 9 | GO:0016301 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.66e-03 | 85 | 79 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase kinase binding | 4.72e-03 | 26 | 79 | 2 | GO:0031435 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 4.89e-06 | 327 | 80 | 9 | GO:0048738 | |
| GeneOntologyBiologicalProcess | heart development | NCOA6 HEG1 SALL1 HEY1 YAP1 SRF ALPK3 DYRK1A APC FGFR2 MED1 CPLANE1 IRX4 | 6.44e-06 | 757 | 80 | 13 | GO:0007507 |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 8.27e-06 | 349 | 80 | 9 | GO:0014706 | |
| GeneOntologyBiologicalProcess | heart trabecula morphogenesis | 1.40e-05 | 38 | 80 | 4 | GO:0061384 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.85e-05 | 212 | 80 | 7 | GO:0003205 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA3 NCOA6 DCAF6 SALL1 HEY1 TBL1Y ATXN7 YAP1 MYT1 ZMYND8 DAB2 SRF KMT2A FGFR2 RAD54L2 MED1 TAF6 | 1.93e-05 | 1390 | 80 | 17 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | 2.15e-05 | 217 | 80 | 7 | GO:0030856 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 2.77e-05 | 91 | 80 | 5 | GO:0003281 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | NCOA3 HEG1 SALL1 HEY1 YAP1 SRF APC ASTN2 FGFR2 MED1 CPLANE1 EXOC4 | 3.05e-05 | 750 | 80 | 12 | GO:0048729 |
| GeneOntologyBiologicalProcess | circulatory system development | NCOA6 HEG1 SALL1 SASH1 PTPRM HEY1 YAP1 AMOTL1 SRF ALPK3 DYRK1A APC FGFR2 MED1 CPLANE1 IRX4 STAB1 | 3.09e-05 | 1442 | 80 | 17 | GO:0072359 |
| GeneOntologyBiologicalProcess | ventricular trabecula myocardium morphogenesis | 3.67e-05 | 17 | 80 | 3 | GO:0003222 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 3.84e-05 | 161 | 80 | 6 | GO:0003231 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA methylation-dependent heterochromatin formation | 4.45e-05 | 3 | 80 | 2 | GO:0090310 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization or depolymerization | 4.56e-05 | 51 | 80 | 4 | GO:0031111 | |
| GeneOntologyBiologicalProcess | trabecula morphogenesis | 7.09e-05 | 57 | 80 | 4 | GO:0061383 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue morphogenesis | 8.12e-05 | 59 | 80 | 4 | GO:0055010 | |
| GeneOntologyBiologicalProcess | branch elongation of an epithelium | 8.20e-05 | 22 | 80 | 3 | GO:0060602 | |
| GeneOntologyBiologicalProcess | embryonic placenta development | 1.00e-04 | 119 | 80 | 5 | GO:0001892 | |
| GeneOntologyBiologicalProcess | regulation of epidermal cell differentiation | 1.05e-04 | 63 | 80 | 4 | GO:0045604 | |
| GeneOntologyBiologicalProcess | labyrinthine layer development | 1.12e-04 | 64 | 80 | 4 | GO:0060711 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 1.21e-04 | 198 | 80 | 6 | GO:0048754 | |
| GeneOntologyBiologicalProcess | positive regulation of stress-activated protein kinase signaling cascade | 1.37e-04 | 26 | 80 | 3 | GO:0070304 | |
| GeneOntologyBiologicalProcess | positive regulation of stress-activated MAPK cascade | 1.37e-04 | 26 | 80 | 3 | GO:0032874 | |
| GeneOntologyBiologicalProcess | regulation of epidermis development | 1.67e-04 | 71 | 80 | 4 | GO:0045682 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermal cell differentiation | 1.72e-04 | 28 | 80 | 3 | GO:0045606 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.75e-04 | 134 | 80 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue growth | 2.00e-04 | 138 | 80 | 5 | GO:0055017 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue development | 2.18e-04 | 76 | 80 | 4 | GO:0003229 | |
| GeneOntologyBiologicalProcess | thelarche | 2.21e-04 | 6 | 80 | 2 | GO:0042695 | |
| GeneOntologyBiologicalProcess | mammary gland branching involved in thelarche | 2.21e-04 | 6 | 80 | 2 | GO:0060744 | |
| GeneOntologyBiologicalProcess | negative regulation of heterochromatin formation | 2.21e-04 | 6 | 80 | 2 | GO:0031452 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue morphogenesis | 2.29e-04 | 77 | 80 | 4 | GO:0055008 | |
| GeneOntologyBiologicalProcess | blood vessel development | NCOA6 HEG1 SASH1 PTPRM HEY1 YAP1 AMOTL1 SRF FGFR2 MED1 CPLANE1 STAB1 | 2.32e-04 | 929 | 80 | 12 | GO:0001568 |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation | 2.48e-04 | 226 | 80 | 6 | GO:0050680 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 2.49e-04 | 321 | 80 | 7 | GO:0003007 | |
| GeneOntologyBiologicalProcess | growth | TAOK2 IGSF10 NCOA3 EYS HEG1 SALL1 YAP1 DAB2 SRF DYRK1A PTCH2 APC FGFR2 MED1 | 2.59e-04 | 1235 | 80 | 14 | GO:0040007 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 2.60e-04 | 228 | 80 | 6 | GO:0046777 | |
| GeneOntologyBiologicalProcess | heart growth | 2.77e-04 | 148 | 80 | 5 | GO:0060419 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermis development | 2.82e-04 | 33 | 80 | 3 | GO:0045684 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 3.06e-04 | 558 | 80 | 9 | GO:0060537 | |
| GeneOntologyBiologicalProcess | bud elongation involved in lung branching | 3.08e-04 | 7 | 80 | 2 | GO:0060449 | |
| GeneOntologyBiologicalProcess | negative regulation of chromatin organization | 3.08e-04 | 7 | 80 | 2 | GO:1905268 | |
| GeneOntologyBiologicalProcess | DNA damage response | TAOK2 PDS5B NCOA6 TAOK3 ATXN7 YAP1 ZMYND8 CHEK2 DYRK1A APC TAOK1 TAF6 | 3.10e-04 | 959 | 80 | 12 | GO:0006974 |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 3.12e-04 | 236 | 80 | 6 | GO:0061138 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 3.18e-04 | 561 | 80 | 9 | GO:0048568 | |
| GeneOntologyBiologicalProcess | vasculature development | NCOA6 HEG1 SASH1 PTPRM HEY1 YAP1 AMOTL1 SRF FGFR2 MED1 CPLANE1 STAB1 | 3.41e-04 | 969 | 80 | 12 | GO:0001944 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | NCOA3 HEG1 SALL1 PTPRM HEY1 YAP1 HCN1 SRF MUC19 APC FGFR2 MED1 IRX4 EXOC4 | 3.42e-04 | 1269 | 80 | 14 | GO:0009887 |
| GeneOntologyBiologicalProcess | mesoderm development | 3.64e-04 | 157 | 80 | 5 | GO:0007498 | |
| GeneOntologyBiologicalProcess | cardiac ventricle morphogenesis | 3.82e-04 | 88 | 80 | 4 | GO:0003208 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 4.08e-04 | 161 | 80 | 5 | GO:0003206 | |
| GeneOntologyBiologicalProcess | regulation of JNK cascade | 4.08e-04 | 161 | 80 | 5 | GO:0046328 | |
| GeneOntologyBiologicalProcess | lacrimal gland development | 4.10e-04 | 8 | 80 | 2 | GO:0032808 | |
| GeneOntologyBiologicalProcess | dorsal aorta morphogenesis | 4.10e-04 | 8 | 80 | 2 | GO:0035912 | |
| GeneOntologyBiologicalProcess | epidermis development | 4.16e-04 | 461 | 80 | 8 | GO:0008544 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 4.30e-04 | 38 | 80 | 3 | GO:0007026 | |
| GeneOntologyBiologicalProcess | axis elongation | 4.30e-04 | 38 | 80 | 3 | GO:0003401 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 4.32e-04 | 163 | 80 | 5 | GO:0007093 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | 4.34e-04 | 464 | 80 | 8 | GO:0045786 | |
| GeneOntologyBiologicalProcess | mitotic DNA damage checkpoint signaling | 4.34e-04 | 91 | 80 | 4 | GO:0044773 | |
| GeneOntologyBiologicalProcess | muscle tissue morphogenesis | 4.71e-04 | 93 | 80 | 4 | GO:0060415 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 4.94e-04 | 596 | 80 | 9 | GO:0001701 | |
| GeneOntologyBiologicalProcess | mitotic G2 DNA damage checkpoint signaling | 5.01e-04 | 40 | 80 | 3 | GO:0007095 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 5.01e-04 | 258 | 80 | 6 | GO:0001763 | |
| GeneOntologyBiologicalProcess | mitotic DNA integrity checkpoint signaling | 5.11e-04 | 95 | 80 | 4 | GO:0044774 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 5.12e-04 | 362 | 80 | 7 | GO:0010948 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 5.78e-04 | 42 | 80 | 3 | GO:0031114 | |
| GeneOntologyBiologicalProcess | skin development | 6.12e-04 | 373 | 80 | 7 | GO:0043588 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle tissue growth | 6.20e-04 | 100 | 80 | 4 | GO:0055021 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | TAOK2 TAOK3 HEG1 PTPRM YAP1 DAB2 SRF APC FGFR2 MED1 DNMBP MUC3A LRP8 | 6.46e-04 | 1194 | 80 | 13 | GO:0000902 |
| GeneOntologyBiologicalProcess | dorsal aorta development | 6.55e-04 | 10 | 80 | 2 | GO:0035907 | |
| GeneOntologyBiologicalProcess | development of secondary female sexual characteristics | 6.55e-04 | 10 | 80 | 2 | GO:0046543 | |
| GeneOntologyBiologicalProcess | muscle organ morphogenesis | 6.68e-04 | 102 | 80 | 4 | GO:0048644 | |
| GeneOntologyBiologicalProcess | mammary gland duct morphogenesis | 7.09e-04 | 45 | 80 | 3 | GO:0060603 | |
| GeneOntologyBiologicalProcess | regulation of stress-activated MAPK cascade | 7.56e-04 | 46 | 80 | 3 | GO:0032872 | |
| GeneOntologyBiologicalProcess | developmental growth | 7.58e-04 | 911 | 80 | 11 | GO:0048589 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | 7.98e-04 | 282 | 80 | 6 | GO:0045930 | |
| GeneOntologyBiologicalProcess | positive regulation of JNK cascade | 8.00e-04 | 107 | 80 | 4 | GO:0046330 | |
| GeneOntologyBiologicalProcess | regulation of heart growth | 8.00e-04 | 107 | 80 | 4 | GO:0060420 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 8.28e-04 | 108 | 80 | 4 | GO:0031110 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | 8.48e-04 | 514 | 80 | 8 | GO:0050678 | |
| GeneOntologyBiologicalProcess | regulation of stress-activated protein kinase signaling cascade | 8.57e-04 | 48 | 80 | 3 | GO:0070302 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | TAOK2 TAOK3 SASH1 CHEK2 DAB2 DYRK1A TAOK1 FBXO33 MAPK9 PRRC1 LRP8 | 9.54e-04 | 937 | 80 | 11 | GO:0031401 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular estrogen receptor signaling pathway | 9.56e-04 | 12 | 80 | 2 | GO:0033148 | |
| GeneOntologyBiologicalProcess | axis specification | 9.81e-04 | 113 | 80 | 4 | GO:0009798 | |
| GeneOntologyBiologicalProcess | placenta development | 1.02e-03 | 197 | 80 | 5 | GO:0001890 | |
| GeneOntologyBiologicalProcess | JNK cascade | 1.04e-03 | 198 | 80 | 5 | GO:0007254 | |
| GeneOntologyBiologicalProcess | signal transduction in response to DNA damage | 1.09e-03 | 200 | 80 | 5 | GO:0042770 | |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 1.13e-03 | 13 | 80 | 2 | GO:0045136 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 1.15e-03 | 118 | 80 | 4 | GO:0001570 | |
| GeneOntologyBiologicalProcess | respiratory system development | 1.20e-03 | 305 | 80 | 6 | GO:0060541 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 1.21e-03 | 817 | 80 | 10 | GO:0048514 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 1.21e-03 | 54 | 80 | 3 | GO:0032968 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell differentiation | 1.21e-03 | 54 | 80 | 3 | GO:0051150 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | NCOA3 HEG1 SALL1 SASH1 PTPRM HEY1 YAP1 AMOTL1 SRF FGFR2 MED1 STAB1 | 1.27e-03 | 1125 | 80 | 12 | GO:0035239 |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | NCOA3 NCOA6 SASH1 YAP1 HCN1 MYT1 CD300LB SRF APC GRB14 FGFR2 MED1 MAPK9 LRP8 | 1.27e-03 | 1450 | 80 | 14 | GO:1901701 |
| GeneOntologyBiologicalProcess | camera-type eye development | 1.33e-03 | 426 | 80 | 7 | GO:0043010 | |
| GeneOntologyBiologicalProcess | regulation of keratinocyte proliferation | 1.34e-03 | 56 | 80 | 3 | GO:0010837 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 1.56e-03 | 217 | 80 | 5 | GO:0000075 | |
| GeneOntologyBiologicalProcess | mitotic G2/M transition checkpoint | 1.56e-03 | 59 | 80 | 3 | GO:0044818 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle phase transition | 1.62e-03 | 219 | 80 | 5 | GO:1901991 | |
| GeneOntologyCellularComponent | Golgi lumen | 5.83e-05 | 109 | 79 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | transcription regulator complex | 8.09e-05 | 596 | 79 | 10 | GO:0005667 | |
| GeneOntologyCellularComponent | chromatin | PDS5B NCOA3 POU6F2 SALL1 HEY1 BAZ2B ATXN7 ZNF618 MYT1 ZMYND8 SRF ZFHX2 MED1 TAF6 IRX4 | 3.81e-04 | 1480 | 79 | 15 | GO:0000785 |
| Domain | SEA | 2.19e-05 | 14 | 75 | 3 | SM00200 | |
| Domain | EGF_3 | 4.38e-05 | 235 | 75 | 7 | PS50026 | |
| Domain | EGF_1 | 7.33e-05 | 255 | 75 | 7 | PS00022 | |
| Domain | EGF_2 | 9.33e-05 | 265 | 75 | 7 | PS01186 | |
| Domain | SEA | 1.04e-04 | 23 | 75 | 3 | PS50024 | |
| Domain | SEA_dom | 1.04e-04 | 23 | 75 | 3 | IPR000082 | |
| Domain | Kinase-like_dom | 3.12e-04 | 542 | 75 | 9 | IPR011009 | |
| Domain | EGF | 3.63e-04 | 235 | 75 | 6 | SM00181 | |
| Domain | SH3_2 | 3.97e-04 | 86 | 75 | 4 | IPR011511 | |
| Domain | SH3_2 | 3.97e-04 | 86 | 75 | 4 | PF07653 | |
| Domain | EGF-like_dom | 4.94e-04 | 249 | 75 | 6 | IPR000742 | |
| Domain | BROMODOMAIN_2 | 5.94e-04 | 41 | 75 | 3 | PS50014 | |
| Domain | EGF-like_CS | 6.32e-04 | 261 | 75 | 6 | IPR013032 | |
| Domain | BROMO | 6.38e-04 | 42 | 75 | 3 | SM00297 | |
| Domain | Bromodomain | 6.38e-04 | 42 | 75 | 3 | IPR001487 | |
| Domain | - | 6.38e-04 | 42 | 75 | 3 | 1.20.920.10 | |
| Domain | Prot_kinase_dom | 7.56e-04 | 489 | 75 | 8 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 7.98e-04 | 493 | 75 | 8 | PS50011 | |
| Domain | RABBD | 1.02e-03 | 12 | 75 | 2 | PS50916 | |
| Domain | TIL | 1.02e-03 | 12 | 75 | 2 | PF01826 | |
| Domain | Rab_BD | 1.02e-03 | 12 | 75 | 2 | IPR010911 | |
| Domain | C8 | 1.02e-03 | 12 | 75 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.21e-03 | 13 | 75 | 2 | IPR014853 | |
| Domain | C8 | 1.21e-03 | 13 | 75 | 2 | SM00832 | |
| Domain | TIL_dom | 1.40e-03 | 14 | 75 | 2 | IPR002919 | |
| Domain | EGF_CA | 1.47e-03 | 122 | 75 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.56e-03 | 124 | 75 | 4 | IPR001881 | |
| Domain | - | 1.62e-03 | 15 | 75 | 2 | 3.30.70.960 | |
| Domain | EGF | 1.66e-03 | 126 | 75 | 4 | PF00008 | |
| Domain | VWD | 1.84e-03 | 16 | 75 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.84e-03 | 16 | 75 | 2 | IPR001846 | |
| Domain | VWFD | 1.84e-03 | 16 | 75 | 2 | PS51233 | |
| Domain | VWD | 1.84e-03 | 16 | 75 | 2 | PF00094 | |
| Domain | CTCK_1 | 2.34e-03 | 18 | 75 | 2 | PS01185 | |
| Domain | PROTEIN_KINASE_ATP | 2.43e-03 | 459 | 75 | 7 | PS00107 | |
| Domain | VWC_out | 2.60e-03 | 19 | 75 | 2 | SM00215 | |
| Domain | Znf_FYVE_PHD | 2.90e-03 | 147 | 75 | 4 | IPR011011 | |
| Domain | Ser/Thr_kinase_AS | 3.11e-03 | 357 | 75 | 6 | IPR008271 | |
| Domain | S_TKc | 3.20e-03 | 359 | 75 | 6 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 3.33e-03 | 362 | 75 | 6 | PS00108 | |
| Domain | PHD | 3.41e-03 | 75 | 75 | 3 | PF00628 | |
| Domain | SEA | 3.49e-03 | 22 | 75 | 2 | PF01390 | |
| Domain | CT | 3.49e-03 | 22 | 75 | 2 | SM00041 | |
| Domain | Znf_PHD-finger | 3.95e-03 | 79 | 75 | 3 | IPR019787 | |
| Domain | Pkinase | 4.27e-03 | 381 | 75 | 6 | PF00069 | |
| Domain | Cys_knot_C | 4.50e-03 | 25 | 75 | 2 | IPR006207 | |
| Domain | CTCK_2 | 4.50e-03 | 25 | 75 | 2 | PS01225 | |
| Domain | AT_hook | 5.23e-03 | 27 | 75 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 5.23e-03 | 27 | 75 | 2 | IPR017956 | |
| Domain | PHD | 5.52e-03 | 89 | 75 | 3 | SM00249 | |
| Domain | Znf_PHD | 5.87e-03 | 91 | 75 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.61e-03 | 95 | 75 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 6.80e-03 | 96 | 75 | 3 | PS01359 | |
| Domain | IG | 6.89e-03 | 421 | 75 | 6 | SM00409 | |
| Domain | Ig_sub | 6.89e-03 | 421 | 75 | 6 | IPR003599 | |
| Domain | EGF_Ca-bd_CS | 7.00e-03 | 97 | 75 | 3 | IPR018097 | |
| Domain | EGF_CA | 7.40e-03 | 99 | 75 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.61e-03 | 100 | 75 | 3 | PS00010 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 4.52e-07 | 16 | 58 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 5.90e-07 | 17 | 58 | 4 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.47e-06 | 21 | 58 | 4 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.15e-06 | 23 | 58 | 4 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 3.60e-06 | 26 | 58 | 4 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.06e-04 | 60 | 58 | 4 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.20e-04 | 62 | 58 | 4 | M546 | |
| Pathway | PID_P38_MKK3_6PATHWAY | 1.61e-04 | 26 | 58 | 3 | M20 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.73e-04 | 68 | 58 | 4 | M27303 | |
| Pathway | WP_MAPK_SIGNALING | 5.03e-04 | 246 | 58 | 6 | M39597 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 4.75e-10 | 18 | 80 | 5 | 18834073 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DOCK3 PHC3 NCOA6 UBAP2 SALL1 AFF2 YAP1 ZMYND8 DAB2 RAD54L2 PRRC1 | 4.43e-09 | 430 | 80 | 11 | 35044719 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NHSL1 NCOA6 UBAP2 SASH1 TTC28 YAP1 PRRC2C DYRK1A APC KMT2A PAN3 DNMBP PRRC1 EXOC4 | 9.72e-09 | 861 | 80 | 14 | 36931259 |
| Pubmed | TAO kinases mediate activation of p38 in response to DNA damage. | 1.17e-08 | 3 | 80 | 3 | 17396146 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDS5B NCOA3 PHC3 NCOA6 ATXN7 YAP1 ZMYND8 DAB2 KMT2A TAOK1 MED1 TAF6 DNMBP | 2.38e-08 | 774 | 80 | 13 | 15302935 |
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 33932349 | ||
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 13679851 | ||
| Pubmed | NCOA3 PHC3 NCOA6 UBAP2 SALL1 TBL1Y ATXN7 YAP1 PRRC2C ZMYND8 TNRC6A KMT2A RAD54L2 PAN3 TAF6 EXOC4 | 1.37e-07 | 1429 | 80 | 16 | 35140242 | |
| Pubmed | DOCK3 DCAF6 TTC28 HEY1 HCN1 ZMYND8 HECTD4 DYRK1A APC ASTN2 TAOK1 RAD54L2 TAF6 EXOC4 STAB1 | 2.10e-07 | 1285 | 80 | 15 | 35914814 | |
| Pubmed | 2.33e-07 | 6 | 80 | 3 | 19110483 | ||
| Pubmed | 5.42e-07 | 549 | 80 | 10 | 38280479 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | UBAP2 AFF2 SYTL2 TNRC6A ZFHX2 MUC16 TAOK1 CPLANE1 MUC3A STAB1 | 5.69e-07 | 552 | 80 | 10 | 10737800 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SALL1 TTC28 YAP1 PRRC2C TNRC6A APC RAD54L2 MAPK9 DNMBP EXOC4 | 1.01e-06 | 588 | 80 | 10 | 38580884 |
| Pubmed | Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche. | 3.30e-06 | 13 | 80 | 3 | 32322056 | |
| Pubmed | 3.62e-06 | 529 | 80 | 9 | 14621295 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 34480788 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 31233836 | ||
| Pubmed | AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis. | 5.23e-06 | 2 | 80 | 2 | 32313226 | |
| Pubmed | Loss of JNK2 increases intestinal tumor susceptibility in Apc1638+/- mice with dietary modulation. | 5.23e-06 | 2 | 80 | 2 | 21183606 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 28830982 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 31913156 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 8758910 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 23739027 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 16828057 | ||
| Pubmed | 5.55e-06 | 418 | 80 | 8 | 34709266 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B PHC3 NCOA6 UBAP2 SALL1 BAZ2B PRRC2C ZMYND8 KMT2A MED1 TAF6 | 1.16e-05 | 954 | 80 | 11 | 36373674 |
| Pubmed | 1.30e-05 | 20 | 80 | 3 | 11877444 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.41e-05 | 341 | 80 | 7 | 32971831 | |
| Pubmed | 1.51e-05 | 21 | 80 | 3 | 19596656 | ||
| Pubmed | Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP. | 1.57e-05 | 3 | 80 | 2 | 21685940 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 22159226 | ||
| Pubmed | YAP1 recruits c-Abl to protect angiomotin-like 1 from Nedd4-mediated degradation. | 1.57e-05 | 3 | 80 | 2 | 22558212 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 32934314 | ||
| Pubmed | PRIP promotes tumor formation through enhancing serum-responsive factor-mediated FOS expression. | 1.57e-05 | 3 | 80 | 2 | 19329434 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 17223341 | ||
| Pubmed | Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression. | 1.57e-05 | 3 | 80 | 2 | 30312684 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 17082781 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 10512748 | ||
| Pubmed | Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades. | 1.57e-05 | 3 | 80 | 2 | 9786855 | |
| Pubmed | JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. | 1.57e-05 | 3 | 80 | 2 | 21364637 | |
| Pubmed | Nuclear actin regulates cell proliferation and migration via inhibition of SRF and TEAD. | 1.57e-05 | 3 | 80 | 2 | 32119877 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 17906291 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 27230679 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 28905448 | ||
| Pubmed | YAP-IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis. | 1.57e-05 | 3 | 80 | 2 | 28130546 | |
| Pubmed | Restriction of intestinal stem cell expansion and the regenerative response by YAP. | 1.57e-05 | 3 | 80 | 2 | 23178811 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 34039707 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 37558679 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 23585562 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 31592798 | ||
| Pubmed | A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness. | 1.57e-05 | 3 | 80 | 2 | 26671411 | |
| Pubmed | 2.11e-05 | 503 | 80 | 8 | 16964243 | ||
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 2.29e-05 | 24 | 80 | 3 | 26116661 | |
| Pubmed | Angiomotin-like proteins associate with and negatively regulate YAP1. | 3.13e-05 | 4 | 80 | 2 | 21187284 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 28416184 | ||
| Pubmed | Angiomotin'g YAP into the nucleus for cell proliferation and cancer development. | 3.13e-05 | 4 | 80 | 2 | 24003252 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 26412716 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 23169490 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 10497253 | ||
| Pubmed | Dyrk1A potentiates steroid hormone-induced transcription via the chromatin remodeling factor Arip4. | 3.13e-05 | 4 | 80 | 2 | 15199138 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 33924850 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 12754253 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 18266782 | ||
| Pubmed | Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated Macrophages. | 3.13e-05 | 4 | 80 | 2 | 32651166 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | POU6F2 DCAF6 TECPR2 ATXN7 MYT1 HECTD4 SRF ZFHX2 ASTN2 PAN3 SYTL1 LRP8 EXOC4 | 3.35e-05 | 1489 | 80 | 13 | 28611215 |
| Pubmed | 3.69e-05 | 268 | 80 | 6 | 33640491 | ||
| Pubmed | PDS5B NCOA3 NCOA6 TAOK3 BAZ2B PRRC2C ZMYND8 KMT2A RAD54L2 MED1 TAF6 | 4.40e-05 | 1103 | 80 | 11 | 34189442 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 4.42e-05 | 908 | 80 | 10 | 19274049 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 4.70e-05 | 170 | 80 | 5 | 23314748 | |
| Pubmed | Checkpoint-dependent phosphorylation of Med1/TRAP220 in response to DNA damage. | 5.20e-05 | 5 | 80 | 2 | 28430840 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 19232126 | ||
| Pubmed | Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter. | 5.20e-05 | 5 | 80 | 2 | 15863722 | |
| Pubmed | Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. | 5.20e-05 | 5 | 80 | 2 | 21205866 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 17360478 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 16101684 | ||
| Pubmed | Cannabinoid Control of Learning and Memory through HCN Channels. | 5.20e-05 | 5 | 80 | 2 | 26898775 | |
| Pubmed | Inhibitory actions of genistein in human breast cancer (MCF-7) cells. | 5.20e-05 | 5 | 80 | 2 | 12853125 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 11912212 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 22683681 | ||
| Pubmed | 5.46e-05 | 89 | 80 | 4 | 18950845 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 6.17e-05 | 180 | 80 | 5 | 35198878 | |
| Pubmed | TAOK2 NCOA3 UBAP2 TBL1Y ZNF618 PRRC2C HCN1 HECTD4 DYRK1A APC | 7.22e-05 | 963 | 80 | 10 | 28671696 | |
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 28848049 | ||
| Pubmed | Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer. | 7.79e-05 | 6 | 80 | 2 | 26503053 | |
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 11027271 | ||
| Pubmed | DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers. | 7.79e-05 | 6 | 80 | 2 | 30137413 | |
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 15919092 | ||
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 7644498 | ||
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 15150259 | ||
| Pubmed | c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer. | 7.79e-05 | 6 | 80 | 2 | 19204086 | |
| Pubmed | The prostate-derived sterile 20-like kinase (PSK) regulates microtubule organization and stability. | 7.79e-05 | 6 | 80 | 2 | 12639963 | |
| Pubmed | Fat depot-specific mRNA expression of novel loci associated with waist-hip ratio. | 7.79e-05 | 6 | 80 | 2 | 23670221 | |
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 16893890 | ||
| Pubmed | Synaptotagmin-like protein 1-3: a novel family of C-terminal-type tandem C2 proteins. | 7.79e-05 | 6 | 80 | 2 | 11243866 | |
| Pubmed | 1.00e-04 | 104 | 80 | 4 | 10470851 | ||
| Pubmed | 1.06e-04 | 469 | 80 | 7 | 27634302 | ||
| Pubmed | 1.09e-04 | 40 | 80 | 3 | 28386764 | ||
| Pubmed | Apolipoprotein E controls ATP-binding cassette transporters in the ischemic brain. | 1.09e-04 | 7 | 80 | 2 | 20923933 | |
| Pubmed | Identification of a melanoma susceptibility locus and somatic mutation in TET2. | 1.09e-04 | 7 | 80 | 2 | 24980573 | |
| Pubmed | YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. | 1.09e-04 | 7 | 80 | 2 | 24976009 | |
| Interaction | YWHAH interactions | NHSL1 NCOA3 NCOA6 UBAP2 SASH1 TTC28 YAP1 PRRC2C HECTD4 DYRK1A APC KMT2A TAOK1 PAN3 MED1 DNMBP PRRC1 EXOC4 | 1.91e-07 | 1102 | 79 | 18 | int:YWHAH |
| Interaction | FEV interactions | 1.31e-06 | 203 | 79 | 8 | int:FEV | |
| Interaction | YWHAG interactions | TAOK2 NHSL1 NCOA6 UBAP2 SASH1 TTC28 YAP1 PRRC2C HECTD4 DYRK1A APC KMT2A TAOK1 PAN3 DNMBP PRRC1 EXOC4 | 5.33e-06 | 1248 | 79 | 17 | int:YWHAG |
| Interaction | ISX interactions | 6.35e-06 | 31 | 79 | 4 | int:ISX | |
| Interaction | TFF1 interactions | 1.98e-05 | 41 | 79 | 4 | int:TFF1 | |
| Interaction | NCOA6 interactions | 2.26e-05 | 145 | 79 | 6 | int:NCOA6 | |
| Interaction | FHL2 interactions | 2.44e-05 | 396 | 79 | 9 | int:FHL2 | |
| Interaction | YWHAQ interactions | NHSL1 NCOA3 NCOA6 UBAP2 SASH1 TTC28 YAP1 HECTD4 DYRK1A APC KMT2A TAOK1 PAN3 MED1 DNMBP | 2.50e-05 | 1118 | 79 | 15 | int:YWHAQ |
| Interaction | CTBP1 interactions | 2.96e-05 | 406 | 79 | 9 | int:CTBP1 | |
| Interaction | NUP43 interactions | PDS5B PHC3 NCOA6 BAZ2B PRRC2C ZMYND8 MUC19 APC KMT2A RAD54L2 TAF6 | 3.12e-05 | 625 | 79 | 11 | int:NUP43 |
| Interaction | HOXC6 interactions | 3.13e-05 | 16 | 79 | 3 | int:HOXC6 | |
| Interaction | CNOT9 interactions | 3.41e-05 | 231 | 79 | 7 | int:CNOT9 | |
| Interaction | TBP interactions | 6.07e-05 | 253 | 79 | 7 | int:TBP | |
| Interaction | HNF4A interactions | 1.02e-04 | 275 | 79 | 7 | int:HNF4A | |
| Interaction | SMAD2 interactions | 1.32e-04 | 385 | 79 | 8 | int:SMAD2 | |
| Interaction | MED1 interactions | 1.59e-04 | 206 | 79 | 6 | int:MED1 | |
| Interaction | UBAP2L interactions | 1.68e-04 | 298 | 79 | 7 | int:UBAP2L | |
| Cytoband | 3p21.2 | 5.03e-04 | 19 | 80 | 2 | 3p21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 6.00e-04 | 219 | 80 | 4 | chr7q22 | |
| Cytoband | 7q22.1 | 1.04e-03 | 113 | 80 | 3 | 7q22.1 | |
| Cytoband | 22q12.1 | 1.44e-03 | 32 | 80 | 2 | 22q12.1 | |
| GeneFamily | CD molecules|Mucins | 3.86e-09 | 21 | 54 | 5 | 648 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 4.88e-05 | 24 | 54 | 3 | 654 | |
| GeneFamily | Synaptotagmin like tandem C2 proteins | 3.88e-04 | 10 | 54 | 2 | 822 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.35e-03 | 161 | 54 | 4 | 593 | |
| GeneFamily | PHD finger proteins | 2.46e-03 | 90 | 54 | 3 | 88 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.51e-03 | 25 | 54 | 2 | 775 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EVI5 PDS5B NCOA3 TAOK3 HEG1 SASH1 TTC28 PTPRM BAZ2B YAP1 PRRC2C ZMYND8 DYRK1A APC MED1 DNMBP | 5.57e-09 | 856 | 80 | 16 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.25e-05 | 466 | 80 | 9 | M13522 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 1.09e-05 | 209 | 77 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.00e-05 | 256 | 77 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.68e-05 | 385 | 77 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.96e-08 | 198 | 80 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.07e-06 | 186 | 80 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.07e-06 | 186 | 80 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.07e-06 | 186 | 80 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-06 | 186 | 80 | 6 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-06 | 190 | 80 | 6 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-06 | 193 | 80 | 6 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-06 | 194 | 80 | 6 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-06 | 196 | 80 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.46e-06 | 196 | 80 | 6 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.46e-06 | 196 | 80 | 6 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-06 | 199 | 80 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-06 | 200 | 80 | 6 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-06 | 200 | 80 | 6 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 176 | 80 | 5 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 176 | 80 | 5 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 1.83e-05 | 180 | 80 | 5 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 180 | 80 | 5 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 180 | 80 | 5 | 7af90f0e7ca001bf1fe5c860ee54c4cc8eb483bf | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 180 | 80 | 5 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | (00)_Basal-(0)_uninjured|(00)_Basal / shred by cell type and Timepoint | 1.93e-05 | 182 | 80 | 5 | c02c9cab4389d80f318f4bb8d703c1e719672624 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 182 | 80 | 5 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.09e-05 | 185 | 80 | 5 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 186 | 80 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-05 | 187 | 80 | 5 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.25e-05 | 188 | 80 | 5 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-05 | 188 | 80 | 5 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.37e-05 | 190 | 80 | 5 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.37e-05 | 190 | 80 | 5 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.43e-05 | 191 | 80 | 5 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 192 | 80 | 5 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-05 | 192 | 80 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 193 | 80 | 5 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 193 | 80 | 5 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 193 | 80 | 5 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 193 | 80 | 5 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 193 | 80 | 5 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 193 | 80 | 5 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 193 | 80 | 5 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-05 | 194 | 80 | 5 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 195 | 80 | 5 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.68e-05 | 195 | 80 | 5 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 196 | 80 | 5 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 197 | 80 | 5 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 197 | 80 | 5 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-05 | 198 | 80 | 5 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 2.89e-05 | 198 | 80 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 198 | 80 | 5 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.96e-05 | 199 | 80 | 5 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.96e-05 | 199 | 80 | 5 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.96e-05 | 199 | 80 | 5 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.03e-05 | 200 | 80 | 5 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 200 | 80 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-05 | 200 | 80 | 5 | 2488aa12970a43a5af352e2c36c73884d73a1cc5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.03e-05 | 200 | 80 | 5 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-05 | 200 | 80 | 5 | 7547d6339f9380d031cfd2cce21ac9a12491e085 | |
| ToppCell | Caecum-Macrophage-Macrophage|Caecum / Region, Cell class and subclass | 3.03e-05 | 200 | 80 | 5 | 99dcf07b17ecf90d596f3b8a12d5b7aae2a351d5 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-05 | 200 | 80 | 5 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | Caecum-(6)_Macrophage-(60)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 3.03e-05 | 200 | 80 | 5 | 67b6cdeb07ffc5c9af7a3e738dd31256cf391e98 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.03e-05 | 200 | 80 | 5 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 200 | 80 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Caecum-(6)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 3.03e-05 | 200 | 80 | 5 | 2ce3930645c3daf6be578f7881e57a58df61e75c | |
| ToppCell | Caecum-Macrophage|Caecum / Region, Cell class and subclass | 3.03e-05 | 200 | 80 | 5 | d83209559187a4419df2508ecc5eb9f7d72fced3 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 200 | 80 | 5 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.03e-05 | 200 | 80 | 5 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-05 | 200 | 80 | 5 | e786544cf6f891550c4be55ebb4928c92297b504 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.03e-05 | 200 | 80 | 5 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | (60)_Macrophage|World / shred on Cell_type and subtype | 3.33e-05 | 204 | 80 | 5 | 06d0cb306f1ad0014d81f8228868938e48c2bcf3 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.70e-05 | 133 | 80 | 4 | d5326a6ccada5ae6d3e8f7d4a858c90050e23c5b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 1.15e-04 | 139 | 80 | 4 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.50e-04 | 149 | 80 | 4 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.75e-04 | 155 | 80 | 4 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 160 | 80 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 160 | 80 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.02e-04 | 161 | 80 | 4 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 168 | 80 | 4 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 168 | 80 | 4 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.43e-04 | 169 | 80 | 4 | c135d7ae0490d0024e0f4bd8c4ad42f6674a61da | |
| ToppCell | facs-Heart-LV-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 170 | 80 | 4 | 4eaa22040e475100061475123aefa32b56481464 | |
| ToppCell | facs-Heart-LV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 170 | 80 | 4 | 60041b2e57e958f300a5bc76851705c8baf297c2 | |
| ToppCell | facs-Heart-LV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 170 | 80 | 4 | 793dde64f5517538b66de5f461a445c4ad6dd7b3 | |
| ToppCell | facs|World / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-04 | 171 | 80 | 4 | bb71e816dde44fda6af0ad98d979be9f8740fda6 | |
| ToppCell | facs|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 171 | 80 | 4 | 5bcb96ed7fc15548f2dc9cf47482f890640cb39c | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 171 | 80 | 4 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-04 | 171 | 80 | 4 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | facs|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 172 | 80 | 4 | a2d0a64ebf09d219a07d6bbad1056bad6d46b9be | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 172 | 80 | 4 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 172 | 80 | 4 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 173 | 80 | 4 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.66e-04 | 173 | 80 | 4 | ec88e871b49331fca59bc610a8ae58e2d5e76bc1 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.66e-04 | 173 | 80 | 4 | 22200fe74e33e2beae0eed289ca8476bbc0b1b2d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 173 | 80 | 4 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.66e-04 | 173 | 80 | 4 | 3a9e9a09b3eeb37cbe56d650e112a8398879477f | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 173 | 80 | 4 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.78e-04 | 175 | 80 | 4 | a8b05972e1bec4de73feaa6c4a9bcbe6b50c8044 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-04 | 176 | 80 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.84e-04 | 176 | 80 | 4 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-04 | 177 | 80 | 4 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.90e-04 | 177 | 80 | 4 | 52c2ba74a8605260a2623e7d151286e504ac4d19 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.96e-04 | 72 | 80 | 3 | 7877184d5c9dd6d96476d71e7504e58c0b4d0f26 | |
| Drug | 5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA | 3.69e-06 | 185 | 79 | 7 | 944_UP | |
| Drug | pivalic anhydride | 3.56e-05 | 3 | 79 | 2 | CID000015234 | |
| Drug | Ellipticine [519-23-3]; Up 200; 16.2uM; HL60; HG-U133A | 4.38e-05 | 184 | 79 | 6 | 1765_UP | |
| Drug | C2SI | 4.39e-05 | 20 | 79 | 3 | CID006327160 | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 4.93e-05 | 188 | 79 | 6 | 4845_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 5.08e-05 | 189 | 79 | 6 | 6649_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 5.23e-05 | 190 | 79 | 6 | 4114_DN | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 5.87e-05 | 194 | 79 | 6 | 4174_DN | |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 6.22e-05 | 196 | 79 | 6 | 3259_UP | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 6.22e-05 | 196 | 79 | 6 | 3331_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 2328_UP | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; PC3; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 6688_UP | |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 6.58e-05 | 198 | 79 | 6 | 3396_UP | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; PC3; HT_HG-U133A | 6.58e-05 | 198 | 79 | 6 | 4603_UP | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 6.58e-05 | 198 | 79 | 6 | 3237_UP | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 6.58e-05 | 198 | 79 | 6 | 5515_UP | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A | 6.76e-05 | 199 | 79 | 6 | 3381_DN | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 6.76e-05 | 199 | 79 | 6 | 6822_DN | |
| Drug | manganese tetroxide | 7.72e-05 | 24 | 79 | 3 | CID000014825 | |
| Disease | serum gamma-glutamyl transferase measurement | EYS SALL1 PTPRM HECTD4 CHEK2 DYRK1A KMT2A ASTN2 FGFR2 DNMBP EXOC4 STAB1 | 6.32e-06 | 914 | 80 | 12 | EFO_0004532 |
| Disease | breast neoplasm | 7.26e-06 | 2 | 80 | 2 | EFO_0003869 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.05e-05 | 16 | 80 | 3 | DOID:331 (implicated_via_orthology) | |
| Disease | neuroticism measurement | DOCK3 POU6F2 TAOK3 AFF2 MARCHF10 HCN1 ZMYND8 DYRK1A KMT2A ASTN2 STAB1 | 3.37e-05 | 909 | 80 | 11 | EFO_0007660 |
| Disease | neuroimaging measurement | TAOK2 NHSL1 STAC2 UBAP2 PRRC2C TNRC6A APC ACTRT2 FGFR2 LRP8 EXOC4 | 1.43e-04 | 1069 | 80 | 11 | EFO_0004346 |
| Disease | coloboma (implicated_via_orthology) | 2.01e-04 | 8 | 80 | 2 | DOID:12270 (implicated_via_orthology) | |
| Disease | ovarian cancer (implicated_via_orthology) | 2.01e-04 | 8 | 80 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | metabolic syndrome | 2.17e-04 | 200 | 80 | 5 | EFO_0000195 | |
| Disease | obsolete_red blood cell distribution width | STAC2 TAOK3 TTC28 MUC17 PILRA BAZ2B ATXN7 PRRC2C HECTD4 CHEK2 TAOK1 OR51V1 | 2.65e-04 | 1347 | 80 | 12 | EFO_0005192 |
| Disease | medulloblastoma (is_implicated_in) | 3.22e-04 | 10 | 80 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | cerebellar volume measurement | 3.85e-04 | 52 | 80 | 3 | EFO_0020864 | |
| Disease | Gastric cancer | 3.93e-04 | 11 | 80 | 2 | cv:C0024623 | |
| Disease | Neoplasm of stomach | 3.93e-04 | 11 | 80 | 2 | cv:C0038356 | |
| Disease | GASTRIC CANCER | 3.93e-04 | 11 | 80 | 2 | 613659 | |
| Disease | tea consumption measurement | 4.26e-04 | 129 | 80 | 4 | EFO_0010091 | |
| Disease | waist-hip ratio | TAOK2 TTC28 SYTL2 HECTD4 TNRC6A DAB2 ASTN2 C11orf24 TAOK1 ACTRT2 STAB1 | 4.61e-04 | 1226 | 80 | 11 | EFO_0004343 |
| Disease | age at first sexual intercourse measurement | 6.16e-04 | 383 | 80 | 6 | EFO_0009749 | |
| Disease | colonic neoplasm, overall survival | 6.47e-04 | 14 | 80 | 2 | EFO_0000638, EFO_0004288 | |
| Disease | cholangiocarcinoma (is_marker_for) | 7.10e-04 | 64 | 80 | 3 | DOID:4947 (is_marker_for) | |
| Disease | hepcidin:transferrin saturation ratio | 7.45e-04 | 15 | 80 | 2 | EFO_0007902 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.90e-04 | 152 | 80 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 8.50e-04 | 16 | 80 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | neuroticism measurement, cognitive function measurement | 8.73e-04 | 566 | 80 | 7 | EFO_0007660, EFO_0008354 | |
| Disease | Benign neoplasm of stomach | 9.61e-04 | 17 | 80 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 9.61e-04 | 17 | 80 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 9.61e-04 | 17 | 80 | 2 | C0154060 | |
| Disease | Limb Deformities, Congenital | 9.61e-04 | 17 | 80 | 2 | C0206762 | |
| Disease | cortical surface area measurement | EVI5 NHSL1 BAZ2B PRRC2C MYT1 TNRC6A APC ASTN2 ACTRT2 FGFR2 LRP8 | 9.89e-04 | 1345 | 80 | 11 | EFO_0010736 |
| Disease | depressive symptom measurement | 1.07e-03 | 426 | 80 | 6 | EFO_0007006 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 1.08e-03 | 18 | 80 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | cup-to-disc ratio measurement | 1.12e-03 | 430 | 80 | 6 | EFO_0006939 | |
| Disease | urinary bladder cancer (is_implicated_in) | 1.17e-03 | 76 | 80 | 3 | DOID:11054 (is_implicated_in) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.36e-03 | 80 | 80 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | Stomach Carcinoma | 1.47e-03 | 21 | 80 | 2 | C0699791 | |
| Disease | depressive symptom measurement, response to antidepressant | 1.78e-03 | 88 | 80 | 3 | EFO_0007006, GO_0036276 | |
| Disease | eye color | 1.90e-03 | 90 | 80 | 3 | EFO_0003949 | |
| Disease | Sjogren's syndrome (is_marker_for) | 1.93e-03 | 24 | 80 | 2 | DOID:12894 (is_marker_for) | |
| Disease | Cerebral Astrocytoma | 2.09e-03 | 25 | 80 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 2.09e-03 | 25 | 80 | 2 | C0750936 | |
| Disease | Astrocytoma | 2.09e-03 | 25 | 80 | 2 | C0004114 | |
| Disease | Grade I Astrocytoma | 2.09e-03 | 25 | 80 | 2 | C1704230 | |
| Disease | breast cancer (implicated_via_orthology) | 2.09e-03 | 25 | 80 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | Subependymal Giant Cell Astrocytoma | 2.09e-03 | 25 | 80 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 2.09e-03 | 25 | 80 | 2 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 2.09e-03 | 25 | 80 | 2 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 2.09e-03 | 25 | 80 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 2.09e-03 | 25 | 80 | 2 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 2.09e-03 | 25 | 80 | 2 | C0338070 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.26e-03 | 26 | 80 | 2 | C0009405 | |
| Disease | response to perphenazine | 2.26e-03 | 26 | 80 | 2 | GO_0097334 | |
| Disease | Gemistocytic astrocytoma | 2.26e-03 | 26 | 80 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 2.26e-03 | 26 | 80 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 2.26e-03 | 26 | 80 | 2 | C0334582 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.44e-03 | 27 | 80 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | Anaplastic astrocytoma | 2.44e-03 | 27 | 80 | 2 | C0334579 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SQSPGLSNMVSSSIT | 271 | Q8TDY3 | |
| SSSTRISNPMDINTT | 1421 | Q8IZF6 | |
| TSVLSTTASSSMGQT | 186 | Q9UIF8 | |
| LSTLMSSSGSNNNLS | 756 | P51816 | |
| ECQTTTAPTMSASSS | 756 | Q96L96 | |
| QQHSPMSSQTSSASG | 386 | Q8IY63 | |
| STLTFNPSSMAVSFT | 1381 | Q6XZF7 | |
| PSTSSTMSAQAHSTS | 411 | Q58WW2 | |
| SPAMEQSQSSGTTSS | 496 | Q13627 | |
| SSTATSVTASNPSFM | 1356 | Q9Y4B4 | |
| QGISSSSTSTMPNSS | 36 | O96017 | |
| SSTSTMPNSSQSSHS | 41 | O96017 | |
| MPNSSQSSHSSSGTL | 46 | O96017 | |
| SMSSSGQLAQATAPT | 176 | O75129 | |
| RLSQTTTPTATMSTA | 2551 | Q9HC84 | |
| RLSQTTTPTATMSTA | 3251 | Q9HC84 | |
| RLSQTTTPTATMSTA | 4536 | Q9HC84 | |
| TATMTRATNSTATPS | 4796 | Q9HC84 | |
| RMETVSNASSSSNPS | 1151 | Q9NTI5 | |
| SSAPQFLMATNSLST | 11 | P78413 | |
| SQASVASSQPVSSEM | 746 | P98082 | |
| SAESSSSMNSNTPLV | 431 | P21802 | |
| TPSQSSSINDISSMS | 386 | P45984 | |
| STQAQDTLSATMSPT | 1551 | Q8WXI7 | |
| MATTSTLGNTSVSTS | 8676 | Q8WXI7 | |
| VSATPALSIQTSSSM | 1796 | Q5T1H1 | |
| PTSLSSLSNAVANTM | 266 | Q7Z6M2 | |
| TPTSNMSSCSLDQTS | 581 | Q5SYE7 | |
| RMITSVSPSTSTNSS | 6 | Q9H2C8 | |
| SMTTALGSQLSSSQT | 7786 | Q7Z5P9 | |
| TNTVTSMTTTASQPT | 266 | Q02505 | |
| SMTTTASQPTATNTL | 271 | Q02505 | |
| TSSLVSMTSATTPNV | 496 | Q02505 | |
| TTNSFTSLTSMPLSS | 656 | Q02505 | |
| TVSQMASQVASPSTS | 41 | O60447 | |
| TSTNLAQMSPTFTTT | 831 | Q9ULI3 | |
| TSSSLTPAMSISASA | 3051 | Q9Y4D8 | |
| TPAMSISASASTSQA | 3056 | Q9Y4D8 | |
| SPTGSVTQQSSMSQT | 111 | Q8NDX5 | |
| MQSRQVSSSSSSPST | 641 | O15265 | |
| SSQSTTMVSPLLTNS | 1786 | Q14686 | |
| MTNSSSSPSLLNDSA | 186 | Q58A45 | |
| NSPTSASQSAGMTVT | 21 | O15488 | |
| QAVTTTTQRPSSMTT | 151 | Q9UKJ1 | |
| SAFSNLSTSQMLSPA | 726 | Q96A65 | |
| YPQMTTLNSTSSTTT | 641 | O60741 | |
| TLNSTSSTTTPTSRM | 646 | O60741 | |
| STSVMQIPSNTLTTA | 1256 | Q6WRI0 | |
| SSSSLSSTHSAPSQM | 1741 | Q8IZD9 | |
| SLSSSSDQNTTSPGM | 2811 | Q9H799 | |
| SLVDSSSSSPSRMNS | 571 | Q8NA82 | |
| MTISNESSQLNTPSS | 141 | A0A0U1RQI7 | |
| SSQSISPMRSISENS | 361 | Q14449 | |
| SSVSSTPSVMETNTS | 3106 | Q03164 | |
| LNVVSMQTTTTPTSS | 3341 | Q03164 | |
| NLSSALGSMSPTTSS | 31 | Q9Y5J3 | |
| AIRMTQSPSSFSAST | 21 | A0A0C4DH67 | |
| VTSSGSMSTLVSSVN | 896 | Q9ULU4 | |
| SPAISESTSSMQALS | 916 | Q9NSC2 | |
| ESTSSMQALSPSNST | 921 | Q9NSC2 | |
| SPISSDQSLSMTSNT | 1536 | Q15648 | |
| RAPQSTSTTTLASTM | 736 | Q14114 | |
| SPSSFTMKTNTLSTS | 821 | P28827 | |
| SEGSTPLTNMSFSTT | 3336 | Q685J3 | |
| STPLMTAQTSGSTST | 576 | Q8NET4 | |
| SVSSLNSSTLSGSQM | 241 | Q8IYJ3 | |
| LTNLSSSSGMTSLSS | 596 | Q9HCH5 | |
| MSSSSSAPSTQQVLS | 541 | P49848 | |
| QASMSQSPVRQASSS | 436 | P78424 | |
| SSSLPQSFARVTTSM | 1146 | Q9Y6C5 | |
| MSQCTSSTIPSSSQE | 766 | Q9Y6Q9 | |
| TSTSPNSQSSKMNSI | 2691 | Q9Y520 | |
| NQSIPSMSISASSQS | 351 | Q7L7X3 | |
| SMSISASSQSSSVNS | 356 | Q7L7X3 | |
| SMSISASSQSSSVNS | 356 | Q9UL54 | |
| PSMSVSTGSQSSSVN | 351 | Q9H2K8 | |
| ATSSFSSPNVSSMES | 36 | Q96M27 | |
| TSTIQTAPSTSTTMQ | 276 | P11831 | |
| MSSSSENTSTPSSNA | 1211 | P25054 | |
| AASTTASSPTNSNMA | 126 | A8K4G0 | |
| ICPMALNSTTSSSTT | 11 | Q17RA5 | |
| TVATTANTSSPMSTR | 216 | Q96F05 | |
| TSSSLNSASPVAMSS | 601 | Q5T6F2 | |
| SANNTTTSGLTPNSM | 446 | Q5T7W0 | |
| MATLNSASTTGTTPS | 1 | Q9C0A1 | |
| LMNRSSFSSTSESPT | 216 | Q6ZMT1 | |
| RTQSSSSLTRTPSMA | 401 | Q9UF83 | |
| TMTTNSSDPFLNSGT | 376 | P46937 | |
| MSGQTVSTTDSSTSN | 521 | O94885 | |
| VPSVSSFSSRTMNAS | 401 | Q9NY15 | |
| SPQSLNTDLLSMTSS | 496 | O15040 | |
| TSNPNSSIMLASASF | 416 | Q9BQ87 | |
| QSMTSLFSNTVSPTQ | 1361 | Q96AY4 | |
| TTNFMTSSLPNSGSV | 456 | Q8NDV7 | |
| STSTQASPDQLISSM | 1016 | Q9H0D2 | |
| SSSMTSPQSSQASRQ | 711 | Q01538 |